Stephen A Sherwin sold $4.1M of Neurocrine Biosciences (NBIX)

Executed Jun 5, disclosed Jun 9, 4 days later.

Value, as filed

$4.1M

25,000 sh across 5 lots

Executed

Jun 5

the trade date, as filed

Disclosed

Jun 9

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SS Stephen A Sherwin Director profile →

Stephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Stephen A Sherwin in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $1.6M
13,831 sh × $116.69
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET